Tim Mullenix, PharmD, Vaccines Medical Director, Pfizer US Medical Affairs
Cortney Patrick, PharmD, Antiviral Medical Director, Pfizer US Medical Affairs
Learning Objectives:
Highlight Paxlovid (nirmatrelvir/ritonavir) approved indications and treatment considerations.
Define high-risk factors for progression to severe COVID-19 and discuss risk factors associated with a greater likelihood of developing Post-COVID Conditions (PCC)
Summarize recommendations regarding Pfizer’s COVID-19 vaccine and identify patient populations who should get the booster.
Description
Please join us for a Lunch and Learn provided by Cortney Patrick, PharmD and Tim Mullenix, PharmD. Both presenters work for Pfizer Medical Affairs and will work together to provide an all-in-one educational webinar to address COVID-19 prevention with vaccination and treatment with Paxlovid (nirmatrelvir/ritonavir). No CE credit will be provided, and no registration is required.
Members and Non-Members: FREE
Date: Thursday, November 9 Time: 12:00 pm - 12:30 pm
No CE Credit Provided
Announcements
ATTENTION
The NCAP Office will be closed from Monday June 24th Through Friday July 5th as NCAP will be working our annual convention, MPJE books may be delayed until after return to office
UPDATE: As of March 1st, 2024 all Member types must renew through the Membership Form, access this form by clicking 'Join/Renew Now' in the top-left
